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Non-thermal atmospheric plasma (NTAP) can be applied to living tissues and cells as a novel 
technology for cancer therapy. We report on a NTAP argon solution generated in deionized water 
(DI) water for treating human gastric cancer cells (NCI-N87). Our findings show that the plasma 
generated in DI water with 30-minute duration has the strongest effect in inducing apoptosis in 
pre-cultured human gastric cancer cells. This result can be attributed to presence of reactive oxygen 
species (ROS) and reactive nitrogen species (RNS) produced in water during treatment. 
Furthermore, the data show that elevated levels of RNS may play more significant role than ROS 
in the rate of gastric cancer cells death. 
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I. INTRODUCTION 
Gastric cancer is one of the most aggressive types of carcinomas and it is known as the second 
most common cause of death1,2. Worldwide, the number of newly diagnosed cases is predicted to 
reach 930,000 per year3. Although gastric cancer is usually managed by chemotherapy or surgery, 
its 5-year survival rate is approximately 15%4. Therefore, efforts to improve survival rates of 
patients with gastric cancer are one of the main challenges in current research. 
Non-thermal atmospheric plasma (NTAP) can be applied to living cells and tissues due to selective 
cell death without influencing the heathy tissue5-11. The unique properties of NTAP have enabled 
recent biomedical applications including wood healing12, sterilization13, blood coagulation14, tooth 
bleaching15, skin regeneration16 and cancer therapy17-20. NTAP is known for the generation of 
charged particles, electronically excited atoms, (Reactive Oxygen Species) ROS, (Reactive 
Nitrogen Species) RNS, etc21,22. ROS and RNS, combined or independently, are known to promote 
cell proliferation as well as cell death. Additionally, extreme amounts of reactive species may lead 
to the damage of DNA, proteins, lipids, senescence and induce apoptosis23,24. Recent studies 
showed that indirect NTAP therapy can significantly affect cancer cells25-27. However, there are 
almost no studies that report on using NTAP to treat gastric cancer cells, let alone NTAP generated 
in DI water. 
This paper presents the effects of NTAP generated in DI water on the gastric cancer cells. NTAP 
device and its characterization are described, as well as the response of cancer cells to the plasma 
solution therapy. The voltage and current of NTAP generated in DI water were measured with a 
Tektronix TDS 2024B Oscilloscope. The spectra of NTAP generated in DI water were 
characterized by UV-visible-NIR Optical Emission Spectroscopy. The plasma density was 
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monitored by Rayleigh Microwave Scattering system (RMS). The temperature of plasma solution 
was measured with FLIR Systems Thermal Imaging. The concentrations of ROS and RNS in DI 
water were determined by using a Fluorimetric Hydrogen Peroxide Assay Kit (Sigma-Aldrich, 
MO), and the Griess Reagent System (Promega, WI), respectively. The cell viability of the human 
gastric cancer cell line (NCI-N87) was monitored with the Cell Counting Kit 8 assay (Dojindo 
Molecular Technologies, MD). 
II. EXPERIMENTAL 
A. UV-Visible Spectrum Analysis 
UV-visible-NIR was investigated on plasma discharged in water with wavelength between 200 
and 850 nm. The spectrometer and the detection probe were purchased from Stellar Net Inc. In 
order to measure the radius of the plasma in DI water, a transparent glass plate was used to replace 
part of the container. The optical probe was placed at a distance of 3.5 cm in front of plasma jet 
nozzle. Integration time of the collecting data was set to 100 ms. 
B. Quantification of ROS and RNS 
Fluorimetric Hydrogen Peroxide Assay Kit (Sigma-Aldrich) was used for measuring the amount 
of H2O2. A detailed protocol can be found on Sigma-Aldrich website. Briefly, we added 50 μl of 
standard curves samples, controls, and experimental samples to the 96-well flat-bottom black 
plates, and then added 50 μl of Master Mix to each well. The plates were incubated for 30 min at 
room temperature protected from light and measured emission of fluorescence by Synergy H1 
Hybrid Multi-Mode Microplate Reader at Ex/Em: 540/590 nm. RNS level was determined by 
Griess Reagent System (Promega Corporation) according to the instructions provided by the 
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manufacturer. Absorbance was measured at 540 nm by Synergy H1 Hybrid Multi-Mode 
Microplate Reader. 
C. Cell lines 
The human gastric cancer cell line (NCI-N87) was bought from American Type Culture Collection 
(ATCC). ATCC is the premier global biological materials resource and standards organization 
whose mission focuses on the acquisition, authentication, production, preservation, development, 
and distribution of standard reference microorganisms, cell lines, and other materials. Cell lines 
were cultured in RPMI-1640 Medium (ATCC® 30-2001™) supplemented with 10% (v/v) fetal 
bovine serum (Atlantic Biologicals). Cultures were maintained at 37 °C in a humidified incubator 
containing 5% (v/v) CO2. 
D. Measurement of cell viability 
The cells were plated in 96-well flat-bottom microplates at a density of 3000 cells per well in 70 
μL of complete culture medium. Confluence of each well was confirmed to be at ~40%. Cells were 
incubated for 24 hours to ensure proper cell adherence and stability. On day 2, 30 μl of RPMI, DI 
water, and plasma solutions were added to the corresponding cells. Cells were further incubated at 
37 °C for another 24 and 48 hours. The viability of the gastric cancer cells was measured with Cell 
Counting Kit 8 assay (Dojindo Molecular Technologies, MD).  The original culture medium was 
aspirated and 10 μL of CCK 8 reagent was added per well. The plates were incubated for 3 hours 
at 37 °C. The absorbance was measured at 450 nm by Synergy H1 Hybrid Multi-Mode Microplate 
Reader. 
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III. RESULTS AND DISCUSSION 
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Fig. 1. Non-thermal atmospheric plasma (NTAP) generated in DI water. (a) Schematic diagram of NTAP device 
setup consisting of a HV pulse generator connected to a pin-to-plate electrode system submerged in DI water. (b) 
Voltage and current waveform. (c) Temperature changes of plasma solution with treating time increasing.  
The utilized plasma device is shown in Fig.1a. Industrial grade argon with a flow rate of about 0.4 
L/min was used for experiments described. The device consisted of 2 electrodes submerged in 
water. One electrode was a central powered electrode (1 mm in diameter) and the other one was a 
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grounded outer electrode wrapped around the outside of a quartz tube (4.5 mm in diameter). The 
two electrodes were connected with a high voltage power supply. The graphs of submerged 
discharge current and voltage are shown in Fig. 1b, with the peak voltage about 8 kV and the 
average current around 0.23 mA. The frequency of the discharge generated in DI water is around 
6.25 kHz. The temperature change of the plasma solutions for different treatment durations is 
shown in Fig. 1c, indicating that the temperature increases with treatment duration. The highest 
temperature increase to 34.4 ± 1.6 °C is achieved at 30 minutes’ plasma treatment. 
The reactive species produced by NTAP generated in DI water are shown in Fig. 2. The 
identification of emission lines and bands was performed according to the reference28. High-
intensity OH/O3 peak at 309 nm and low-intensity N2 second-positive system (𝐶3Π𝑢 − 𝐵
3Π𝑔) with 
its peaks at 337, 358, and 381 nm were observed. Argon lines observed in the range of 600 and 
800 nm are shown in Fig. 2.  
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Fig. 2 Optical emission spectrum detected from the plasma submerged in DI water using UV-visible-NIR, a range of 
wavelength 250-850 nm 
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Fig. 3. H2O2 (a) and NO2- (b) concentration in plasma stimulated DI water. H2O2 and NO2- concentration are 
calculated by the concentration ratio of experimental group and control group. DI water volume is 200 ml. 
NTAP can produce chemically active species in DI water. Plasma discharge produced ROS and 
RNS in DI water in a time-dependent manner, as shown in Fig. 3a and Fig. 3b, respectively. In 
order to compare the generation efficiency of ROS and RNS, we measured concentration of H2O2 
and NO2
- in the case of the submerged NTAP device. H2O2 was produced in DI water within a few 
microseconds from hydroxyl (•OH)29. On the other hand, gas phase H2O2 in the afterglow also 
solvated into the DI water. Following mechanisms of H2O2 formation in our cases can be 
suggested24,30-33. 
Ar → Ar+ + e                                              (1) 
Ar+ + H2O → H2O+ + Ar                            (2) 
H2O
+ + H2O → H3O+ + •OH                      (3) 
Ar + e → Ar* + e                                        (5) 
Ar* + H2O → Ar + •OH + H•                     (6) 
e + H2O → H2O* + e                                   (7) 
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H2O* → •OH + H•                                       (8) 
ℎ𝑣 + H2O → •OH + H•                                 (9) 
•OH + •OH → H2O2                                     (10) 
According to Arrhenius theory34, the decomposition rate of H2O2 increases with temperature. The 
temperature of the plasma solution increased with treatment time (Fig.1c), which might explain 
the decrease of H2O2 concentration. 
Fig. 3b shows that the NO2
- concentration increases with treatment time. The NO2
- mainly 
originated as NO, while most of NO was formed in the gas phase during the afterglow a few 
milliseconds after the discharge pulse. It is known that NO2
- is a primary breakdown product of 
NO in DI water35 and through the following pathways36. 
N2 + e → 2N + e                                           (11) 
N + O2 → NO + O                                        (12) 
4NO + O2 + 2H2O → 4NO2- + 4H+              (13) 
Due to DI water contact with air, it is plausible to assume that O2 and perhaps N2 is coming from 
air. On the other hand, N2 is perhaps coming from the industrial grade argon. Thus reactions (11), 
(12) and (13) can be used to explain the production NO2
- in argon gas 
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Fig. 4. The effects of the five solutions: RPMI, DI water (0 min), and plasma solutions generated in DI water during 
5, 10, 20, and 30 min, on the cell viability of the human gastric cancer cells (NCI-N87). The cancer cells were plated 
in 96-well plates with 30 ul of plasma solutions and were incubated at 37 °C in 5% CO2 for 24 hours (a) and 48 
hours (b). The ratio of surviving cells from each treatment condition were calculated relative to controls. 
Plasma generated in DI water was applied to gastric cancer cells. RPMI and untreated DI water 
were used as the control conditions. Fig. 4 shows the viability of the human gastric cancer when 
they were exposed to RPMI, DI water and plasma solution (5, 10, 20, and 30 mins) for 24 hours 
and 48 hours. At 24 hours, the viability decreased by 15.8% when the cells were treated with DI 
water in comparison with the RPMI control condition (Fig. 4a). The viability of cells treated by 
plasma solution was lower than that of the DI water and decreased with increasing treatment time. 
At 48 hours the viability of the cell decreased by approximately 22.6%, 28.2%, 30.9%, 41.6%, and 
45.7% respectively according to treatment duration. (Fig. 4(b)). A decrease in cell viability was 
accompanied with an increase in the concentration of nitrite and a decrease in the concentration of 
H2O2. Thus, it can be seen that the strongest effect can be observed at 30 min plasma solution. 
ROS and RNS are important signal mediators that regulate cell death35. When the cell is stimulated 
by environmental stress or other factors, it produces ROS that are potential signaling molecules37. 
Extreme amount of ROS in the cells may cause DNA damage, genetic instability, cellular injury 
and eventually induce apoptosis. RNS are pleiotropic mediators and signaling molecules involved 
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in a large number of cell functions38. In some situations, RNS activate the transduction pathways 
causing cells apoptosis and are capable of inducing cell death via DNA double-strands 
break/apoptosis39,40. On the other hand, ROS reacts with RNS to form peroxynitrite. It leads either 
to caspase activation followed by apoptosis or to lipid peroxidation, protein nitration or oxidation, 
which can result into necrosis41. Our results in Fig. 3 show that the ROS concentration is highest 
at 5-minute treatment while the RNS concentration is highest at 30 minutes. The trend of cell death 
can be attributed to the increase of RNS concentration with increasing treatment time. A 
synergistic effect of RNS and ROS is suspected to play a key role in the apoptosis effect of plasma 
solution. In fact, RNS play a more important role that ROS in gastric cancer cell apoptosis under 
the present experimental condition. 
IV. CONCLUSIONS 
In summary, non-thermal atmospheric plasma was generated in DI water using argon as a carrier 
gas. NTAP argon solutions were applied for treating human gastric cancer cells (NCI-N87). ROS 
concentration decreased with extended treatment time, while RNS concentration increased with 
treatment. Plasma generated in DI water during a 30-minute treatment has the strongest affect in 
inducing cells death. It can also be concluded that RNS plays a more significant role in gastric 
cancer cells death than ROS. 
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